Spots Global Cancer Trial Database for ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
Official Title: Accelerated Super-Hypofractionated Breast Brachytherapy - ASHBY Trial
Study ID: NCT06185205
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to compare any good and bad effects of giving radiation treatment for breast cancer in 3 treatments over about 2 days.
Detailed Description: This phase 2, single-arm prospective study has been designed to determine the safety of delivering accelerated partial breast irradiation (APBI) with a multicatheter interstitial implant in a short course over 1.5 days
Eligibility
Minimum Age: 45 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Virginia Commonwealth University, Richmond, Virginia, United States
Contact Details
Name: Bridget Quinn, MD, Ph.D
Affiliation: Virginia Commonwealth University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
